Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.7 HKD | +0.15% |
|
-2.19% | +0.30% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Neutral |
Resistance | 6.980 | 7.450 | 9.890 |
Spread/Res. | -4.01% | -10.07% | -32.25% |
Spread/Supp. | +1.21% | +14.73% | +40.17% |
Support | 6.620 | 5.840 | 4.780 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 1477 Stock
- Charts Ocumension Therapeutics